SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Oct-24 7:55 AM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Oct-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 50% 28.51K to 42.88K | |
07-Oct-24 7:55 AM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Oct-24 | Planned Option Sale | 14,375 | $54.63 | $785,306.00 | (34%) 42.88K to 28.51K | |
05-Jul-24 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jul-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 50% 28.51K to 42.88K | |
05-Jul-24 4:30 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jul-24 | Planned Option Sale | 14,375 | $44.87 | $645,006.00 | (34%) 42.88K to 28.51K | |
25-Jun-24 5:03 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 24-Jun-24 | Option Exercise | 9,500 | $16.89 | $160,455.00 | 34% 27.79K to 37.29K | |
25-Jun-24 5:03 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 24-Jun-24 | Option Sale | 9,500 | $45.73 | $434,435.00 | (25%) 37.29K to 27.79K | |
17-Apr-24 4:36 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 52% 27.79K to 42.16K | |
17-Apr-24 4:36 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Planned Option Sale | 14,375 | $44.47 | $639,256.00 | (34%) 42.16K to 27.79K | |
22-Mar-24 4:52 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 50% 28.5K to 42.88K | |
22-Mar-24 4:52 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Option Sale | 14,375 | $44.06 | $633,307.00 | (34%) 42.88K to 28.5K | |
22-Mar-24 4:52 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Sale | 714 | $44.06 | $31,456.10 | (3%) 28.5K to 27.79K | |
20-Mar-24 6:36 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 411 | $38.14 | $15,675.50 | (1%) 28.91K to 28.5K | |
06-Mar-24 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 23,000 | -- | -- | 389% 5.91K to 28.91K | |
04-Jan-24 4:45 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jan-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 243% 5.91K to 20.29K | |
04-Jan-24 4:45 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jan-24 | Planned Option Sale | 14,375 | $35.00 | $503,125.00 | (71%) 20.29K to 5.91K | |
22-Dec-23 6:45 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 21-Dec-23 | Option Exercise | 9,583 | $16.89 | $161,857.00 | 162% 5.91K to 15.49K | |
22-Dec-23 6:45 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 21-Dec-23 | Option Sale | 9,583 | $34.57 | $331,284.00 | (62%) 15.49K to 5.91K | |
05-Apr-23 7:12 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 05-Apr-23 | Sale | 8,212 | $16.15 | $132,624.00 | (65%) 12.71K to 4.5K | |
05-Apr-23 7:12 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Apr-23 | Payment of Exercise | 4,288 | $15.98 | $68,522.20 | (25%) 17.0K to 12.71K | |
03-Mar-23 4:44 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Mar-23 | Grant | 4,500 | -- | -- | 36% 12.5K to 17.0K | |
11-Oct-22 4:35 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 10-Oct-22 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K |